Cargando…

Two-Pronged Treatment of Hemoperitoneum and Abnormal Uterine Bleeding in an Adolescent Girl With Congenital Fibrinogen Deficiency

Introduction: If a woman suffers from congenital fibrinogen deficiency (CFD), she might undergo hypermenorrhea monthly and possibly to suffer from hemoperitoneum due to a ruptured follicle or corpus luteal cyst every month, which seriously threaten her health and quality of life. Here, we creatively...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yiran, Zhao, Lanbo, Feng, Xue, Li, Qing, Ma, Sijia, Liang, Dongxin, Liu, Mingge, Yin, Panyue, Li, Qiling, Lu, Qinrui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7253637/
https://www.ncbi.nlm.nih.gov/pubmed/32509792
http://dx.doi.org/10.3389/fmed.2020.00181
_version_ 1783539371164565504
author Wang, Yiran
Zhao, Lanbo
Feng, Xue
Li, Qing
Ma, Sijia
Liang, Dongxin
Liu, Mingge
Yin, Panyue
Li, Qiling
Lu, Qinrui
author_facet Wang, Yiran
Zhao, Lanbo
Feng, Xue
Li, Qing
Ma, Sijia
Liang, Dongxin
Liu, Mingge
Yin, Panyue
Li, Qiling
Lu, Qinrui
author_sort Wang, Yiran
collection PubMed
description Introduction: If a woman suffers from congenital fibrinogen deficiency (CFD), she might undergo hypermenorrhea monthly and possibly to suffer from hemoperitoneum due to a ruptured follicle or corpus luteal cyst every month, which seriously threaten her health and quality of life. Here, we creatively used a combination of the levonorgestrel-releasing intrauterine system (LNG-IUS) and the combined oral contraceptives (COC) for a girl with CFD. Case presentation: A 14-year-old girl presented with no obvious cause of persistent and severe lower abdominal pain that began 8 h prior. After examination, she was diagnosed as hemoperitoneum. CFD was diagnosed when she was 2 years old and she had two hospitalizations due to hemorrhagic anemia caused by menorrhagia. Therefore, after successful conservative treatment of hemoperitoneum, a combination of LNG-IUS and COC was used for the long-term conservative management of hypermenorrhea and hemoperitoneum. During the half-year of follow-up, she had hypomenorrhea without hemoperitoneum. Conclusions: To the best of our knowledge, this was the first patient treated with such a procedure in the literature, and we recommend every woman with CFD at puberty or reproductive age receives this two-pronged treatment.
format Online
Article
Text
id pubmed-7253637
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-72536372020-06-05 Two-Pronged Treatment of Hemoperitoneum and Abnormal Uterine Bleeding in an Adolescent Girl With Congenital Fibrinogen Deficiency Wang, Yiran Zhao, Lanbo Feng, Xue Li, Qing Ma, Sijia Liang, Dongxin Liu, Mingge Yin, Panyue Li, Qiling Lu, Qinrui Front Med (Lausanne) Medicine Introduction: If a woman suffers from congenital fibrinogen deficiency (CFD), she might undergo hypermenorrhea monthly and possibly to suffer from hemoperitoneum due to a ruptured follicle or corpus luteal cyst every month, which seriously threaten her health and quality of life. Here, we creatively used a combination of the levonorgestrel-releasing intrauterine system (LNG-IUS) and the combined oral contraceptives (COC) for a girl with CFD. Case presentation: A 14-year-old girl presented with no obvious cause of persistent and severe lower abdominal pain that began 8 h prior. After examination, she was diagnosed as hemoperitoneum. CFD was diagnosed when she was 2 years old and she had two hospitalizations due to hemorrhagic anemia caused by menorrhagia. Therefore, after successful conservative treatment of hemoperitoneum, a combination of LNG-IUS and COC was used for the long-term conservative management of hypermenorrhea and hemoperitoneum. During the half-year of follow-up, she had hypomenorrhea without hemoperitoneum. Conclusions: To the best of our knowledge, this was the first patient treated with such a procedure in the literature, and we recommend every woman with CFD at puberty or reproductive age receives this two-pronged treatment. Frontiers Media S.A. 2020-05-21 /pmc/articles/PMC7253637/ /pubmed/32509792 http://dx.doi.org/10.3389/fmed.2020.00181 Text en Copyright © 2020 Wang, Zhao, Feng, Li, Ma, Liang, Liu, Yin, Li and Lu. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Medicine
Wang, Yiran
Zhao, Lanbo
Feng, Xue
Li, Qing
Ma, Sijia
Liang, Dongxin
Liu, Mingge
Yin, Panyue
Li, Qiling
Lu, Qinrui
Two-Pronged Treatment of Hemoperitoneum and Abnormal Uterine Bleeding in an Adolescent Girl With Congenital Fibrinogen Deficiency
title Two-Pronged Treatment of Hemoperitoneum and Abnormal Uterine Bleeding in an Adolescent Girl With Congenital Fibrinogen Deficiency
title_full Two-Pronged Treatment of Hemoperitoneum and Abnormal Uterine Bleeding in an Adolescent Girl With Congenital Fibrinogen Deficiency
title_fullStr Two-Pronged Treatment of Hemoperitoneum and Abnormal Uterine Bleeding in an Adolescent Girl With Congenital Fibrinogen Deficiency
title_full_unstemmed Two-Pronged Treatment of Hemoperitoneum and Abnormal Uterine Bleeding in an Adolescent Girl With Congenital Fibrinogen Deficiency
title_short Two-Pronged Treatment of Hemoperitoneum and Abnormal Uterine Bleeding in an Adolescent Girl With Congenital Fibrinogen Deficiency
title_sort two-pronged treatment of hemoperitoneum and abnormal uterine bleeding in an adolescent girl with congenital fibrinogen deficiency
topic Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7253637/
https://www.ncbi.nlm.nih.gov/pubmed/32509792
http://dx.doi.org/10.3389/fmed.2020.00181
work_keys_str_mv AT wangyiran twoprongedtreatmentofhemoperitoneumandabnormaluterinebleedinginanadolescentgirlwithcongenitalfibrinogendeficiency
AT zhaolanbo twoprongedtreatmentofhemoperitoneumandabnormaluterinebleedinginanadolescentgirlwithcongenitalfibrinogendeficiency
AT fengxue twoprongedtreatmentofhemoperitoneumandabnormaluterinebleedinginanadolescentgirlwithcongenitalfibrinogendeficiency
AT liqing twoprongedtreatmentofhemoperitoneumandabnormaluterinebleedinginanadolescentgirlwithcongenitalfibrinogendeficiency
AT masijia twoprongedtreatmentofhemoperitoneumandabnormaluterinebleedinginanadolescentgirlwithcongenitalfibrinogendeficiency
AT liangdongxin twoprongedtreatmentofhemoperitoneumandabnormaluterinebleedinginanadolescentgirlwithcongenitalfibrinogendeficiency
AT liumingge twoprongedtreatmentofhemoperitoneumandabnormaluterinebleedinginanadolescentgirlwithcongenitalfibrinogendeficiency
AT yinpanyue twoprongedtreatmentofhemoperitoneumandabnormaluterinebleedinginanadolescentgirlwithcongenitalfibrinogendeficiency
AT liqiling twoprongedtreatmentofhemoperitoneumandabnormaluterinebleedinginanadolescentgirlwithcongenitalfibrinogendeficiency
AT luqinrui twoprongedtreatmentofhemoperitoneumandabnormaluterinebleedinginanadolescentgirlwithcongenitalfibrinogendeficiency